Loading companies
Loading company profiles, tickers, sectors, and latest research coverage.
Loading company profiles, tickers, sectors, and latest research coverage.
Find company pages that collect related theses, catalysts, risks, filings, and discussion in one place.
Browse curated company pages by ticker, exchange, or research theme.
Array Digital Infrastructure: the tower stock with a parent buyout shadow
Open company ->ADAC: the $230 million blank check that still has to find a real company
Open company ->Adagene: the masked-antibody bet trying to outrun dilution
Open company ->Adamas Trust: the dividend looks covered, but the repo market gets a vote
Open company ->Adobe: the cash machine AI is supposed to defend, not destroy
Open company ->Agree Realty: boring retail, aggressive buying, and a balance sheet built for rates
Open company ->ADC Therapeutics: the lymphoma readout trying to beat the royalty wall
Open company ->Adeia: the patent tollbooth where AI chips, streaming, and a CEO exit collide
Open company ->Adagio Medical: the $12.9M cash clock behind a make-or-break VT filing
Open company ->Analog Devices: the analog chip giant riding AI racks while factories thaw
Open company ->Adial Pharmaceuticals: the cheek-swab alcohol-use pill racing a 2026 runway
Open company ->ADM's $80B Food Chain Is Betting 2026 on Biofuels Clarity and a Trust Reset
Open company ->ADMA's ASCENIV Rocket Just Met the IVIG Pricing Wall
Open company ->Adient: The $14.5 Billion Seat Maker Still Fighting for Every Margin Point
Open company ->ADP: The Payroll Tollbooth Hiding a $48 Billion Interest-Rate Lever
Open company ->Adaptive Biotechnologies: Can clonoSEQ outrun the cash-burn clock?
Open company ->ADS-TEC Energy: The Charging Pivot That Has To Survive A Revenue Cliff
Open company ->Autodesk: The Design Software Toll Road AI Could Either Widen Or Undercut
Open company ->ADT: The Home Security Cash Machine Now Has To Prove AI Is More Than A Yard Sign
Open company ->ADTRAN: Fiber Spending Is Back, Now The Balance Sheet Gets A Vote
Open company ->Aditxt: The Biotech Roll-Up Fighting Nasdaq Before It Fights Disease
Open company ->Aduro: C$39M Cash, Tiny Revenue, And One Plant That Has To Work
Open company ->Addus: A $1.4B Home-Care Roll-Up Riding Medicaid's Tightrope
Open company ->Advantage Solutions: Retail Muscle, 4.2x Leverage, And A Branded-Services Problem
Open company ->